For the first time, privately-owned Stada has acknowledged the potential for a sale of the business – six years after the private equity duo Bain Capital and Cinven announced a deal worth upwards of €5.4bn for the German firm.
Bain Capital and Cinven are considering the possibility of selling STADA Arzneimittel AG, the company’s CEO Peter Goldschmidt has acknowledged, almost exactly six years to the day since the private equity duo took control of the Germany-based, European generics and biosimilars giant.
Goldschmidt’s comments, made to the German Press Agency, follow reports in Bloomberg earlier this month that Bain and Cinven were...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
